AbbVie: Balancing its blockbusters with its CMO business
Five-year forecasting and careful project selection help AbbVie manage its 13 manufacturing sites to meet both its own pipeline and CMO customer needs, the firm says. Spun-out from Abbott Laboratories in 2013, AbbVie is one of the largest biopharma firms driven by its lead blockbuster biologic Hu ...
In its 10-year history, Pfenex has evolved from a service firm and a technology provider to a biologics developer in its own right.
In October ...
Servier has selected Pall Corporation as its exclusive technology and services provider at its biomanufacturing facility in Gidy, France.
The ...
With its own facilities, support from Novartis and now dedicated space at Catalent’s Paragon, AveXis says it has the most gene therapy manufact ...
J&J has reported a 57% year-on-year growth for its multiple myeloma monoclonal antibody Darzalex (daratumumab) and is now hoping to increase ...
Recent Tweets
-
RT @Dan5tanton: J&J has reported 57% year-on-year growth for its #multiplemyeloma monoclonal antibody Darzalex and is now hoping to… https://t.co/nt3kkGe1M6
3 days ago
-
RT @Dan5tanton: Kite will build a 67,000 square-foot facility within its parent company Gilead’s site in Oceanside, California to e… https://t.co/ucdPJg3fWA
4 days ago
-
Boehringer Ingelheim to buy cancer vaccine firm AMAL - The $365m acquisition is latest boost in the immune cell-di… https://t.co/Su3nVXiuVB
4 days ago
-
RT @Dan5tanton: ADC Bio has completed construction of a cleanroom in Wales, part of an $11m bioconjugation facility to serve demand… https://t.co/8ONhj1Js3U
4 days ago
Trending
Manufacturing
Manufacturing of Cell and Gene Therapies
Analytical
Biopharmaceutical Characterization, Part 2: Applications and Strategies for Diverse Products — A Conference Report
Manufacturing
eBook: Allogeneic Cell Therapies Commercialization Strategies
Manufacturing
Immunotherapy: Taking Aim at Solid Cancers